CEM(SZ:002980)2023-04-28 16:00Financial Performance - The company's operating revenue for 2022 was CNY 596,775,379.37, a decrease of 19.36% compared to CNY 740,051,644.74 in 2021[18]. - The net profit attributable to shareholders for 2022 was CNY 98,242,651.87, down 34.02% from CNY 148,888,059.88 in the previous year[18]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 87,468,040.16, a decrease of 32.97% from CNY 130,489,628.25 in 2021[18]. - The basic earnings per share for 2022 was CNY 0.74, down 33.93% from CNY 1.12 in 2021[18]. - The total assets at the end of 2022 were CNY 1,159,754,497.49, a decrease of 3.07% from CNY 1,196,465,650.69 at the end of 2021[18]. - The net assets attributable to shareholders at the end of 2022 were CNY 1,015,841,691.22, down 4.35% from CNY 1,062,074,049.72 in 2021[18]. - The net cash flow from operating activities increased by 60.32% to CNY 52,177,675.36 from CNY 32,545,946.89 in the previous year[18]. - The company reported a net profit attributable to shareholders of 98.24 million yuan, a year-on-year decrease of 34.02%[19]. - The total operating costs for the main business amounted to CNY 343,236,390.61, a decrease of 21.68% compared to CNY 438,251,821.06 in the previous year[104]. - The revenue from the instrument manufacturing industry was ¥571.59 million, accounting for 95.78% of total revenue, with a year-on-year decline of 22.07%[98]. - The company achieved a gross margin of 39.95% in the instrument manufacturing sector, which decreased by 0.30% compared to the previous year[99]. - The company's overseas revenue was ¥515.99 million, representing 86.46% of total revenue, down 22.51% from the previous year[98]. - The domestic revenue increased by 8.94% to ¥80.78 million, accounting for 13.54% of total revenue[98]. Research and Development - R&D expenses increased to 75.31 million yuan from 58.31 million yuan, representing a year-on-year growth of 29.15%[20]. - The company is focused on enhancing its R&D capabilities in high-end products and technologies, aligning with national policies supporting the instrument manufacturing industry[30]. - The company aims to enhance its innovation capabilities in precision instruments, focusing on key components like oscilloscopes and spectrum analyzers[31]. - The company has established a MEMS/NEMS R&D base to improve its technological competitiveness in sensor development[113]. - The number of R&D personnel rose to 190, a 10.47% increase from 2021, with a significant rise in younger staff under 30 years old by 118.92%[113]. - R&D investment increased by 29.15% to ¥75,309,692.20 in 2022, accounting for 12.62% of operating revenue[113]. - The company is actively enhancing its investment in R&D for in vitro diagnostic instruments and reagents, with key products under development including a nucleic acid extraction detection integrated machine capable of completing 384 target detections in 1 hour[63]. Market and Product Development - The company is actively expanding into emerging markets such as medical testing and renewable energy[36]. - The company has launched innovative products, including a multifunctional digital multimeter with an integrated thermal imaging feature[38]. - The company is implementing a dual-driven strategy of "technology + market" to enhance its market presence[35]. - The company has developed a series of "thermal imager +" products, combining thermal imaging with multimeters, clamp meters, and insulation testers, creating significant technological advantages[45]. - The company has developed multiple rapid test kits for respiratory infectious diseases, including five products that have received EU professional CE certification[61]. - The company is focused on expanding its market presence through new product development and strategic investments in technology[112]. - The company is actively pursuing opportunities for market expansion and potential mergers and acquisitions to drive growth[184]. Governance and Management - The company maintained a robust governance structure, ensuring compliance with relevant laws and regulations, which supports its sustainable development and shareholder rights[160]. - The company held four shareholder meetings during the reporting period, ensuring equal treatment of all shareholders and adherence to legal voting procedures[161]. - The board of directors consists of 8 members, including 3 independent directors, and held 6 meetings during the reporting period[163]. - The supervisory board comprises 3 members, including 1 employee representative, and also held 6 meetings during the reporting period[164]. - The company emphasizes the protection of stakeholders' rights and maintains communication with shareholders, employees, and society[166]. - The company has established a complete and independent financial accounting system, with no shared bank accounts with controlling shareholders[171]. - The company has a fully independent research, procurement, production, and sales system, with no reliance on controlling shareholders for operations[174]. Challenges and Risks - The company faced multiple production stoppages during the reporting period, impacting overall operations[18]. - The company faces uncertainty regarding its ability to continue as a going concern, as indicated by negative net profits over the last three accounting years[20]. - The company faces risks from international trade policies and exchange rate fluctuations, which may impact overseas business performance[153]. - The company is addressing raw material price volatility risks by optimizing supply chain resources and controlling costs through technology upgrades[154]. Employee and Training - The total number of employees at the end of the reporting period is 1,352, with 1,177 from the parent company and 175 from major subsidiaries[196]. - The professional composition includes 938 production personnel, 120 sales personnel, 190 technical personnel, 30 financial personnel, and 74 administrative personnel[196]. - A comprehensive annual training plan is established to improve employee quality and work efficiency, covering various aspects such as professional skills and safety management[199]. - The company emphasizes a diversified incentive mechanism based on team and individual performance, enhancing employee motivation and creativity[197]. Future Outlook - The company aims to enhance its core business while further deepening existing industries and clients, focusing on structural optimization and transformation[146]. - The company will continue to increase R&D investment, emphasizing technology innovation and the accumulation of proprietary technology, with a focus on aligning R&D with market demand[147]. - The company plans to strengthen brand building through various channels, aiming to enhance its market share and competitiveness[148].